Jason L. Eriksen - Publications

University of Houston, Houston, TX, United States 
Alzheimer's disease

53 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Guo J, Artur C, Womack T, Eriksen JL, Mayerich D. Multiplex protein-specific microscopy with ultraviolet surface excitation. Biomedical Optics Express. 11: 99-108. PMID 32010503 DOI: 10.1364/BOE.11.000099  1
2019 Guo J, Artur C, Eriksen JL, Mayerich D. Three-Dimensional Microscopy by Milling with Ultraviolet Excitation. Scientific Reports. 9: 14578. PMID 31601843 DOI: 10.1038/s41598-019-50870-1  1
2018 Govyadinov PA, Womack T, Chen G, Mayerich D, Eriksen J. Robust Tracing and Visualization of Heterogeneous Microvascular Networks. Ieee Transactions On Visualization and Computer Graphics. PMID 29993636 DOI: 10.1109/TVCG.2018.2818701  1
2018 Jarvela TS, Womack T, Georgiou P, Gould TD, Eriksen JL, Lindberg I. 7B2 chaperone knockout in APP model mice results in reduced plaque burden. Scientific Reports. 8: 9813. PMID 29955078 DOI: 10.1038/s41598-018-28031-7  1
2018 Artur CG, Womack T, Zhao F, Eriksen JL, Mayerich D, Shih WC. Plasmonic nanoparticle-based expansion microscopy with surface-enhanced Raman and dark-field spectroscopic imaging. Biomedical Optics Express. 9: 603-615. PMID 29552397 DOI: 10.1364/BOE.9.000603  1
2016 Tanifum EA, Ghaghada K, Vollert C, Head E, Eriksen JL. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. Journal of Alzheimer's Disease : Jad. 54: 1251. PMID 27716679 DOI: 10.3233/JAD-169008  1
2016 Tanifum EA, Ghaghada K, Vollert C, Head E, Eriksen JL, Annapragada A. A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging. Journal of Alzheimer's Disease : Jad. PMID 27031484 DOI: 10.3233/JAD-151124  1
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Eriksen JL, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.01
2015 Manchandani P, Zhou J, Ledesma KR, Truong LD, Chow DS, Eriksen JL, Tam VH. Characterization of Polymyxin B Bio-distribution and Disposition in an Animal Model. Antimicrobial Agents and Chemotherapy. PMID 26643340 DOI: 10.1128/AAC.02445-15  0.01
2015 Vollert CT, Moree WJ, Gregory S, Bark SJ, Eriksen JL. Formaldehyde scavengers function as novel antigen retrieval agents. Scientific Reports. 5: 17322. PMID 26612041 DOI: 10.1038/srep17322  1
2014 Ohia-Nwoko O, Montazari S, Lau YS, Eriksen JL. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Molecular Neurodegeneration. 9: 54. PMID 25432085 DOI: 10.1186/1750-1326-9-54  0.08
2014 Dao AT, Zagaar MA, Salim S, Eriksen JL, Alkadhi KA. Regular exercise prevents non-cognitive disturbances in a rat model of Alzheimer's disease. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 593-602. PMID 24229510 DOI: 10.1017/S1461145713001351  1
2014 Vollert C, Ohia O, Akasaka H, Berridge C, Ruan KH, Eriksen JL. Elevated prostacyclin biosynthesis in mice impacts memory and anxiety-like behavior. Behavioural Brain Research. 258: 138-44. PMID 24140503 DOI: 10.1016/j.bbr.2013.10.012  1
2014 Hoshino A, Helwig M, Rezaei S, Berridge C, Eriksen JL, Lindberg I. A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease. Journal of Neurochemistry. 128: 419-30. PMID 24102330 DOI: 10.1111/jnc.12454  1
2013 Vollert C, Forkuo GS, Bond RA, Eriksen JL. Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory. Neuroscience Letters. 548: 296-300. PMID 23748072 DOI: 10.1016/j.neulet.2013.05.052  1
2013 Hazra A, Gu F, Aulakh A, Berridge C, Eriksen JL, Ziburkus J. Inhibitory neuron and hippocampal circuit dysfunction in an aged mouse model of Alzheimer's disease. Plos One. 8: e64318. PMID 23691195 DOI: 10.1371/journal.pone.0064318  1
2013 Dao AT, Zagaar MA, Levine AT, Salim S, Eriksen JL, Alkadhi KA. Treadmill exercise prevents learning and memory impairment in Alzheimer's disease-like pathology. Current Alzheimer Research. 10: 507-15. PMID 23627709 DOI: 10.2174/1567205011310050006  1
2013 Thanawala VJ, Forkuo GS, Al-Sawalha N, Azzegagh Z, Nguyen LP, Eriksen JL, Tuvim MJ, Lowder TW, Dickey BF, Knoll BJ, Walker JK, Bond RA. β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model. American Journal of Respiratory Cell and Molecular Biology. 48: 220-9. PMID 23204390 DOI: 10.1165/rcmb.2012-0364OC  1
2013 Helwig M, Hoshino A, Berridge C, Lee SN, Lorenzen N, Otzen DE, Eriksen JL, Lindberg I. The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. The Journal of Biological Chemistry. 288: 1114-24. PMID 23172224 DOI: 10.1074/jbc.M112.417071  1
2012 Tanifum EA, Dasgupta I, Srivastava M, Bhavane RC, Sun L, Berridge J, Pourgarzham H, Kamath R, Espinosa G, Cook SC, Eriksen JL, Annapragada A. Intravenous delivery of targeted liposomes to amyloid-β pathology in APP/PSEN1 transgenic mice. Plos One. 7: e48515. PMID 23119043 DOI: 10.1371/journal.pone.0048515  1
2011 Sun L, Eriksen JL. Recent insights into the involvement of progranulin in frontotemporal dementia. Current Neuropharmacology. 9: 632-42. PMID 22654721 DOI: 10.2174/157015911798376361  0.96
2010 Eriksen JL. The enigmatic roles of microglial versus neuronal progranulin in neurological disease. Acta Neuropathologica. 119: 107-9. PMID 20012633 DOI: 10.1007/s00401-009-0623-z  0.01
2009 Cook C, Gass J, Dunmore J, Tong J, Taylor J, Eriksen J, McGowan E, Lewis J, Johnston J, Petrucelli L. Aging is not associated with proteasome impairment in UPS reporter mice. Plos One. 4: e5888. PMID 19517018 DOI: 10.1371/journal.pone.0005888  1
2008 Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Human Molecular Genetics. 17: 3631-42. PMID 18723524 DOI: 10.1093/hmg/ddn257  1
2008 Eriksen JL, Zehr C, Lewis J. Biologic models of neurodegenerative disorders. Handbook of Clinical Neurology. 89: 173-88. PMID 18631742 DOI: 10.1016/S0072-9752(07)01216-X  1
2008 Kukar TL, Ladd TB, Bann MA, Fraering PC, Narlawar R, Maharvi GM, Healy B, Chapman R, Welzel AT, Price RW, Moore B, Rangachari V, Cusack B, Eriksen J, Jansen-West K, et al. Substrate-targeting gamma-secretase modulators. Nature. 453: 925-9. PMID 18548070 DOI: 10.1038/nature07055  1
2008 Eriksen JL, Mackenzie IR. Progranulin: normal function and role in neurodegeneration. Journal of Neurochemistry. 104: 287-97. PMID 17953663 DOI: 10.1111/j.1471-4159.2007.04968.x  0.16
2007 Weggen S, Rogers M, Eriksen J. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends in Pharmacological Sciences. 28: 536-43. PMID 17900710 DOI: 10.1016/j.tips.2007.09.004  1
2007 Kukar T, Prescott S, Eriksen JL, Holloway V, Murphy MP, Koo EH, Golde TE, Nicolle MM. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. Bmc Neuroscience. 8: 54. PMID 17650315 DOI: 10.1186/1471-2202-8-54  1
2007 Eriksen JL, Janus CG. Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behavior Genetics. 37: 79-100. PMID 17072762 DOI: 10.1007/s10519-006-9118-z  1
2007 Weggen S, Czirr E, Leuchtenberger S, Eriksen J. Nonsteroidal anti-inflammatory drugs (NSAIDs) and derived Aβ42-lowering molecules for treatment and prevention of Alzheimer's disease (AD) Pharmacological Mechanisms in Alzheimer's Therapeutics. 167-193. DOI: 10.1007/978-0-387-71522-3_11  1
2006 Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, ... ... Eriksen J, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442: 916-9. PMID 16862116 DOI: 10.1038/nature05016  1
2006 Amtul Z, Kausar N, Follmer C, Rozmahel RF, Atta-Ur-Rahman, Kazmi SA, Shekhani MS, Eriksen JL, Khan KM, Choudhary MI. Cysteine based novel noncompetitive inhibitors of urease(s)--distinctive inhibition susceptibility of microbial and plant ureases. Bioorganic & Medicinal Chemistry. 14: 6737-44. PMID 16859909 DOI: 10.1016/j.bmc.2006.05.078  1
2006 Le Corre S, Klafki HW, Plesnila N, Hübinger G, Obermeier A, Sahagún H, Monse B, Seneci P, Lewis J, Eriksen J, Zehr C, Yue M, McGowan E, Dickson DW, Hutton M, et al. An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 9673-8. PMID 16769887 DOI: 10.1073/pnas.0602913103  1
2006 McGowan E, Eriksen J, Hutton M. A decade of modeling Alzheimer's disease in transgenic mice. Trends in Genetics : Tig. 22: 281-9. PMID 16567017 DOI: 10.1016/j.tig.2006.03.007  1
2005 McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, et al. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 47: 191-9. PMID 16039562 DOI: 10.1016/j.neuron.2005.06.030  1
2005 Dickey CA, Eriksen J, Kamal A, Burrows F, Kasibhatla S, Eckman CB, Hutton M, Petrucelli L. Development of a high throughput drug screening assay for the detection of changes in tau levels -- proof of concept with HSP90 inhibitors. Current Alzheimer Research. 2: 231-8. PMID 15974923 DOI: 10.2174/1567205053585927  1
2005 Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, Ozols VV, Anastasiadis PZ, Das P, et al. Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nature Medicine. 11: 545-50. PMID 15834426 DOI: 10.1038/nm1235  1
2005 Eriksen JL, Wszolek Z, Petrucelli L. Molecular pathogenesis of Parkinson disease. Archives of Neurology. 62: 353-7. PMID 15767499 DOI: 10.1001/archneur.62.3.353  1
2005 Eriksen JL, Przedborski S, Petrucelli L. Gene dosage and pathogenesis of Parkinson's disease. Trends in Molecular Medicine. 11: 91-6. PMID 15760766 DOI: 10.1016/j.molmed.2005.01.001  1
2004 Eriksen JL, Petrucelli L. Parkinson's disease - Molecular mechanisms of disease Drug Discovery Today: Disease Mechanisms. 1: 399-405. DOI: 10.1016/j.ddmec.2004.11.016  1
2003 Eriksen JL, Dawson TM, Dickson DW, Petrucelli L. Caught in the act: alpha-synuclein is the culprit in Parkinson's disease. Neuron. 40: 453-6. PMID 14642269 DOI: 10.1016/S0896-6273(03)00684-6  1
2003 Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. The Journal of Clinical Investigation. 112: 440-9. PMID 12897211 DOI: 10.1172/JCI18162  1
2003 Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Ozols V, Fauq A, Golde TE, Koo EH. Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. The Journal of Biological Chemistry. 278: 31831-7. PMID 12805356 DOI: 10.1074/jbc.M303592200  1
2003 Tajuddin NF, Orrico LA, Eriksen JL, Druse MJ. Effects of ethanol and ipsapirone on the development of midline raphe glial cells and astrocytes. Alcohol (Fayetteville, N.Y.). 29: 157-64. PMID 12798971  1
2003 Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Golde TE, Koo EH. Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain. The Journal of Biological Chemistry. 278: 30748-54. PMID 12777371 DOI: 10.1074/jbc.M304824200  1
2002 Eriksen JL, Gillespie R, Druse MJ. Effects of ethanol and 5-HT1A agonists on astroglial S100B. Brain Research. Developmental Brain Research. 139: 97-105. PMID 12480124  1
2002 Golde TE, Eriksen JL, Weggen S, Sagi SA, Koo EH. Nonsteroidal antiinflammatory drugs as therapeutic agents for Alzheimer's disease Drug Development Research. 56: 415-420. DOI: 10.1002/ddr.10093  1
2001 Eriksen JL, Druse MJ. Astrocyte-mediated trophic support of developing serotonin neurons: effects of ethanol, buspirone, and S100B. Brain Research. Developmental Brain Research. 131: 9-15. PMID 11718831  1
2001 Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 414: 212-6. PMID 11700559 DOI: 10.1038/35102591  1
2001 Eriksen JL, Druse MJ. Potential involvement of S100B in the protective effects of a serotonin-1a agonist on ethanol-treated astrocytes. Brain Research. Developmental Brain Research. 128: 157-64. PMID 11412901  1
2000 Eriksen JL, Gillespie RA, Druse MJ. Effects of in utero ethanol exposure and maternal treatment with a 5-HT(1A) agonist on S100B-containing glial cells. Brain Research. Developmental Brain Research. 121: 133-43. PMID 10876026  1
1999 Druse MJ, Hao HL, Eriksen JL. In utero ethanol exposure increases proenkephalin, a precursor of a neuropeptide that is inhibitory to neuronal growth. Alcoholism, Clinical and Experimental Research. 23: 1519-27. PMID 10512319  1
Show low-probability matches.